For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
These are some of the trends in weight management retailers and manufacturers are keeping an eye on in the new year to help ...
The company reported progress in external distribution agreements, including initiatives to co-package pen needles with generic GLP-1 drugs ... $110 million in debt reduction for FY2025.
After just a few years on the market, a new wave of GLP-1 drugs approved for weight loss have upended what we know about obesity. By now, these are household names: Mounjaro. Wegovy. Zepbound ...
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
Feb. 5, 2025 /PRNewswire/ -- The American College of Clinical Pharmacology ® (ACCP) published a recent Position Paper entitled "Ensuring the Appropriate Use of Glucagon-Like Peptide-1 Receptor ...
BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision ... She adds that a rapid reduction in blood glucose levels, which is the ...
Keep reading for a complete list of instant chart-toppers throughout history. 1. "You Are Not Alone" by Michael Jackson Michael Jackson was the first artist to achieve this feat with "You Are Not ...
The relative reduction in major adverse cardiovascular events (MACE) with SGLT2 inhibitors was greater in older versus younger participants, but the relative reduction in MACE with GLP-1 receptor ...
(2017). Given its long-lasting GLP-1 actions and potential clinical compliance, it is of great interests to investigate whether supaglutide exerts cardioprotective effects in both preclinical and ...
Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...
GLP-1: Glucagon-like peptide-1 ... Published and preliminary data have shown once-weekly exenatide to result in greater A1c reduction than exenatide twice daily; and as a second- or third-line ...